Since October 2011 the PHIS website is no longer maintained.

Please refer from now on to the website of the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies:

PHIS project

Publication of the PHIS Hospital Pharma Report

The PHIS Hospital Pharma Report, which was compiled by PHIS project leader GÖG/ÖBIG together with WP Hospital Pharma leader SUKL, allows gaining insight into medicines management in hospitals. The report offers an overview on purchasing policies and financing strategies for medicines in the in-patient sector in 27 countries (European overview) and case studies including a price comparison in 25 hospitals in five countries (Austria, Norway, the Netherland, Portugal, Slovakia). More information can be obtained here PHIS Hospital Report.

The main findings of the PHIS Hospital Pharma Report were translated into German and are also available under the section PHIS Hospital Report .

PHIS (Pharmaceutical Health Information System) is an European Commission funded project, commissioned by the Executive Agency for Health and Consumers under the call for proposals 2007 in the priority area "health information" of the European Commission, DG Sanco, and co-funded by the Austrian Ministry of Health.

The PHIS project runs from September 2008 to April 2011 (32 months).

The PHIS project aims at increasing knowledge and exchange of information on pharmaceutical policies, in particular on pricing and reimbursement, in the EU Member States, covering both the out-patient and the in-patient sector.

This will be done via different work packages resulting in the following deliverables:

  • the PHIS Glossary with key terms related to pharmaceuticals
  • the PHIS Library, offering country specific information on out-patient and in-patient pharmaceutical pricing and reimbursement for the EU Member States
  • the PHIS Indicators and the PHIS Database, containing key data for the developed indicators in the EU Member States
  • the PHIS Hospital Pharma Report with information on pharmaceutical policies in the inpatient sector in the EU Member States, including a price survey
  • the PHIS network comprising national representatives (competent authorities, Third Party Payers, hospital associations) and European stakeholders in the field of pharmaceuticals.

The PHIS project management is a consortium of the project leader Gesundheit Österreich GmbH, Geschäftsbereich Österreichisches Bundesinstitut für Gesundheitswesen / Austrian Health Institute (GÖG/ÖBIG) a research institute situated in Vienna, Austria, and four associated partners: the Italian Medicines Agency (AIFA), Italy, the International Healthcare and Health Insurance Institute (IHHII), Bulgaria, SOGETI Luxembourg SA., Luxembourg and the State Institute for Drug Control (SUKL), Slovakia.

Further key stakeholders of the PHIS project management are the PHIS advisory board covering EU Commission services and agencies and international organisations, and the PHIS network, which comprises national representatives from competent authorities and further relevant institutions from the EU Member States and associated countries.

A brief description of the PHIS project can be found in the PHIS leaflet.